XML 30 R21.htm IDEA: XBRL DOCUMENT
v3.22.1

Net Income Per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2022
Earnings Per Share [Abstract] |
Schedule of computation of basic and diluted net income per share | The following table shows the computation of basic and diluted net income per share for the three months ended March 31, 2022 and 2021:
|  | Three Months Ended March 31, |
(In thousands except per share data) |  | 2022 |  |  | 2021 |
Numerator: |  |  |  |  |  |
Net income attributable to Innoviva stockholders, basic |  | $ | 15,773 |  |  | $ | 94,123 |
Add: interest expense on 2023 Notes |  |  | 1,021 |  |  |  | 1,204 |
Add: interest expense on 2025 Notes |  |  | 1,164 |  |  |  | — |
Add: interest expense on 2028 Notes |  |  | 384 |  |  |  | — |
Net income attributable to Innoviva stockholders, diluted |  | $ | 18,342 |  |  | $ | 95,327 |
Denominator: |  |  |  |  |  |
Weighted-average shares used to compute basic net income per share attributable to Innoviva stockholders |  |  | 69,544 |  |  |  | 101,365 |
Dilutive effect of 2023 Notes |  |  | 10,155 |  |  |  | 12,189 |
Dilutive effect of 2025 Notes |  |  | 11,150 |  |  |  | — |
Dilutive effect of 2028 Notes |  |  | 2,765 |  |  |  | — |
Dilutive effect of options and awards granted under equity incentive plan and employee stock purchase plan |  |  | 116 |  |  |  | 70 |
Weighted-average shares used to compute diluted net income per share attributable to Innoviva stockholders |  |  | 93,730 |  |  |  | 113,624 |
Net income per share attributable to Innoviva stockholders |  |  |  |  |  |
Basic |  | $ | 0.23 |  |  | $ | 0.93 |
Diluted |  | $ | 0.20 |  |  | $ | 0.84 |
Schedule of anti-dilutive securities | The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti-dilutive for the periods presented:
|  | Three Months Ended March 31, |
(In thousands) |  | 2022 |  |  | 2021 |
Outstanding options and awards granted under equity incentive plan and employee stock purchase plan |  |  | 386 |  |  |  | 1,159 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration